ETON ▲ +1.6% - Eton Pharmaceuticals, Inc.
$ETON - Eton Pharmaceuticals Announces Licensing and Initiation of ET-900 Program Evaluating Mecasermin/IGF-1 for Treatment of Infantile and Epileptic Spasms
02-NOV-2026 06:50 AM ET
Share this post
More filings for $ETON
ETON - Eton Pharmaceuticals, Inc. - SEC Filing Update (06-NOV-2026) | ThinkSabio - Stocks SimplifiedNov 6, 2026ETON ▲ +15.7% - Eton Pharmaceuticals, Inc.Nov 5, 2026ETON ▲ +13.3% - Eton Pharmaceuticals, Inc.Nov 5, 2026ETON ▼ -7.1% - Eton Pharmaceuticals, Inc.Nov 5, 2026ETON ▼ -0.5% - Eton Pharmaceuticals, Inc.Nov 4, 2026ETON ▲ +1.6% - Eton Pharmaceuticals, Inc.Nov 2, 2026
View full $ETON filing history →💬 Comments
Loading comments…
Leave a comment
